LSD, Psilocybin, and 2C-B Each Leave a Distinct Fingerprint on the Brain, New Study Finds

• The study found that LSD, psilocybin, and 2C-B produce distinct patterns of brain activity in rats, as revealed by PET scans.
• The research compared the effects of the three compounds side by side, showing that each drug affects different brain networks.
• 2C-B and LSD had more pronounced effects during the active phase of the drugs, while psilocybin showed effects after the drugs had worn off.

• The study highlights that psychedelics may not be interchangeable in medical applications due to their distinct brain activity patterns.
• The findings suggest that different compounds might be better suited for different disorders, but the results are based on animal models and not human data.
• The researchers acknowledge the limitations of the study, noting that human trials are needed to confirm the findings.

• The study provides a biological foundation for understanding how different psychedelics alter brain metabolism and connectivity.
• It does not determine if the differences between the compounds will translate to human medicine, but it offers a starting point for further research.

AI-generated summary of the original article — see the source for the full story.